Feasibility of 6-month maintenance cetuximab after adjuvant concurrent chemoradiation plus cetuximab in squamous cell carcinoma of the head and neck

Title
Feasibility of 6-month maintenance cetuximab after adjuvant concurrent chemoradiation plus cetuximab in squamous cell carcinoma of the head and neck
Authors
Keywords
Adverse effects, Clinical trial, phase II, Head and neck neoplasms, Toxicity, Interim analysis,  Unerwünschte Nebenwirkungen, Klinische Phase-II-Studie, Kopf-Hals-Neoplasien, Toxizität, Interimanalyse
Journal
STRAHLENTHERAPIE UND ONKOLOGIE
Volume 189, Issue 8, Pages 625-631
Publisher
Springer Nature
Online
2013-07-03
DOI
10.1007/s00066-013-0378-2

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started